The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so ...

Novartis’ Aimovig (erenumab) has been approved by the European Medicines ... pain and nausea symptoms associated with migraines. The new treatment will be available as a SureClick autoinjector ...

“With many current drugs to prevent migraine, it takes time to find the right dosage for the individual and it can take weeks ...

The FDA has approved Eli Lilly’s new migraine drug lasmiditan, offering patients a new option to relieve symptoms should they feel an attack coming on. Under the brand name Reyvow, Lilly’s ...

Recent clinical research has unveiled groundbreaking results for Atogepant, a preventive medication offering new hope for chronic migraine sufferers. The comprehensive study published in Neurology ...

A drug recently approved to prevent migraine may start working right away ... study author of Albert Einstein College of Medicine in the Bronx, New York, and a Fellow of the American Academy ...

Atogepant, a recently approved drug for migraine, may start working as soon as day 1 of treatment ... Lipton, MD, of Albert Einstein College of Medicine in the Bronx, New York, in a press release.

Triptans is a medication that can help relieve migraine symptoms. Research has found it effective, but it’s not for everyone. Migraine is a neurological condition affecting millions of people ...

A drug recently approved to prevent migraine may start working right away ... Lipton, MD, of Albert Einstein College of Medicine in the Bronx, New York, and a Fellow of the American Academy ...

I tried every medication that's ... but there is new hope for migraine sufferers. It's called CGRP-targeted therapy, and the FDA has approved the first drugs in this new class of treatments.

You can also get in touch in the following ways: Atogepant is a new type of anti-calcitonin gene-related peptide (CGRP) drug, which is specifically designed to treat migraines. They work by ...

A new drug for chronic migraines could make "a massive difference ... but the NHS in Scotland approved it recently. Phil Ranson, from NICE, said although they did not recommend the drug in ...